![Sara Johanna K. Malcus Pellmé](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sara Johanna K. Malcus Pellmé
Director Ejecutivo en MetaboGen AB .
Cargos activos de Sara Johanna K. Malcus Pellmé
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MetaboGen AB
![]() MetaboGen AB Internet Software/ServicesTechnology Services MetaboGen AB operates a metagenome and metabolic disease platform. It provides commercial access to metagenome research and development. The firm offers create next generation probiotics and pharmaceutical products, based on the microbiome. The company was founded in 2011 and is headquartered in Göteborg, Sweden. | Director Ejecutivo | 01/01/2015 | - |
Historial de carrera de Sara Johanna K. Malcus Pellmé
Antiguos cargos conocidos de Sara Johanna K. Malcus Pellmé.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GU Ventures AB
![]() GU Ventures AB Investment ManagersFinance GU Ventures AB (GU Ventures) is a venture capital subsidiary of University of Gothenburg founded in 1995. The firm is headquartered in Gothenburg, Sweden. | Inversor de Capital Privado | 01/05/2008 | 31/05/2014 |
CERENO SCIENTIFIC AB | Director/Miembro de la Junta | - | - |
Oncorena Holding AB
![]() Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Director/Miembro de la Junta | - | - |
VICORE PHARMA HOLDING AB | Director/Miembro de la Junta | 01/01/2018 | - |
Independent Dir/Board Member | 01/01/2018 | - | |
Arterion AB
![]() Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | - | - |
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Presidente | - | - |
bioMérieux, Inc.
![]() bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | Corporate Officer/Principal | - | - |
ORTOMA AB | Presidente | 01/05/2008 | - |
Formación de Sara Johanna K. Malcus Pellmé.
University of Gothenburg | Doctorate Degree |
Estadísticas
Internacional
Suecia | 10 |
Estados Unidos | 2 |
Operativa
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
President | 1 |
Sectorial
Health Technology | 7 |
Health Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ORTOMA AB | Health Services |
VICORE PHARMA HOLDING AB | Health Technology |
CERENO SCIENTIFIC AB | Health Technology |
Empresas privadas | 6 |
---|---|
bioMérieux, Inc.
![]() bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | Health Technology |
MetaboGen AB
![]() MetaboGen AB Internet Software/ServicesTechnology Services MetaboGen AB operates a metagenome and metabolic disease platform. It provides commercial access to metagenome research and development. The firm offers create next generation probiotics and pharmaceutical products, based on the microbiome. The company was founded in 2011 and is headquartered in Göteborg, Sweden. | Technology Services |
GU Ventures AB
![]() GU Ventures AB Investment ManagersFinance GU Ventures AB (GU Ventures) is a venture capital subsidiary of University of Gothenburg founded in 1995. The firm is headquartered in Gothenburg, Sweden. | Finance |
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Arterion AB
![]() Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
Oncorena Holding AB
![]() Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |